Dual gene deficient models of ApcMin/+ mouse in assessing molecular mechanisms of intestinal carcinogenesis

Biomed Pharmacother. 2018 Dec:108:600-609. doi: 10.1016/j.biopha.2018.09.056. Epub 2018 Sep 20.

Abstract

The ApcMin/+ mouse, carrying an inactivated allele of the adenomatous polyposis coli (Apc) gene, is a widely used animal model of human colorectal tumorigenesis. While crossed with other gene knockout or knock-in mice, these mice possess advantages in investigation of human intestinal tumorigenesis. Intestinal tumor pathogenesis involves multiple gene alterations; thus, various double gene deficiency models could provide novel insights into molecular mechanisms of tumor biology, as well as gene-gene interactions involved in intestinal tumor development and assessment of novel strategies for preventing and treating intestinal cancer. This review discusses approximately 100 double gene deficient mice and their associated intestinal tumor development and progression phenotypes. The dual gene knockouts based on the Apc mutation background consist of inflammation and immune-related, cell cycle-related, Wnt/β-catenin signaling-related, tumor growth factor (TGF)-signaling-related, drug metabolism-related, and transcription factor genes, as well as some oncogenes and tumor suppressors. Future studies should focus on conditional or inducible dual or multiple mouse gene knockout models to investigate the molecular mechanisms underlying intestinal tumor development, as well as potential drug targets.

Keywords: Apc(Min/+)mice; Double gene deficiency; Gene mutation; Intestinal tumor; Mouse model.

Publication types

  • Review

MeSH terms

  • Adenomatous Polyposis Coli / genetics*
  • Animals
  • Carcinogenesis / genetics*
  • Disease Models, Animal
  • Humans
  • Intestinal Neoplasms / genetics*
  • Mice
  • Mutation / genetics